[Involvement of natriuretic peptides in pathophysiology of maternal and fetal disorders during pregnancy].
Sagawa
Norimasa
N
Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine.
D001238:Asphyxia Neonatorum / Q000175:diagnosis / Q000209:etiology*; D015415:Biomarkers / Q000097:blood; D001775:Blood Circulation; D006152:Cyclic GMP / Q000502:physiology; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000209:etiology*; D005317:Fetal Growth Retardation / Q000175:diagnosis / Q000209:etiology; D006162:Guanylate Cyclase / Q000502:physiology; D006801:Humans; D000860:Hypoxia / Q000175:diagnosis / Q000209:etiology*; D007231:Infant, Newborn; D045265:Natriuretic Peptides / Q000097:blood / Q000502:physiology*; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000209:etiology*; D011247:Pregnancy; D017461:Receptors, Atrial Natriuretic Factor / Q000502:physiology; D014590:Uterine Contraction; D014599:Uterus / Q000098:blood supply; D000099242:Atrial Natriuretic Factor Receptor B
D015415:Biomarkers; D006152:Cyclic GMP; D006162:Guanylate Cyclase; D045265:Natriuretic Peptides; D017461:Receptors, Atrial Natriuretic Factor; D000099242:Atrial Natriuretic Factor Receptor B; C091715:atrial natriuretic factor receptor A